INSIGHTS ON LIQUID DOSE MANUFACTURING

• Water For Injection: Strategic Utility And The Case For Outsourcing

  Water for Injection is a critical, highly regulated component of sterile drug manufacturing. Outsourcing its production offers faster timelines, reduced risk, and improved operational and cost efficiency.

• Understanding Injectable Drug Container Closure Systems

  Choosing the right container closure system (CCS) format is crucial, so understanding the different parts involved, their functions, storage requirements, and how they impact administering the drug is essential.

• Seasonal Vaccine Manufacturing: 3 Areas To Evaluate When Selecting A Partner

  Experienced outsourcing partners will have the right facility and technical capabilities, a culture of speed and execution, and shared expectations and commitment to continuous improvement.

• Contamination Control Of Particulate And Shuttle Blow-Fill-Seal Compliance

  Does shuttle blow-fill-seal truly meet Annex 1’s stricter contamination standards? New particle burden data challenges industry assumptions and reveals what manufacturers need to know.

• Quality Assurance In Pharmaceutical Water For Injection (WFI) Systems

  3/19/2026

  Maintaining the integrity of Water for Injection (WFI) systems is a non-negotiable priority in pharmaceutical manufacturing. Watch this webinar to refine your contamination control strategies.

• Syntegon Virtual Pharma Expo May 2025: Aseptic Manufacturing And Packaging

  5/21/2025

  The 2022 EU GMP Annex 1 revision marks a pivotal shift in sterile manufacturing, emphasizing contamination control, advanced technologies, and global harmonization—driving industry-wide adaptation and regulatory interpretation challenges.

• Drug Substance To Fill-Finish Handoff: What Sponsors Need To Know

  5/14/2026

  Effective drug substance handoff to fill-finish manufacturing depends on early collaboration, clear communication, and proactive planning to reduce risks, ensure quality, and maintain timelines.

• Solve ATMP Aseptic Filling Challenges With Gloveless Isolators

  1/9/2026

  Human intervention is the top contamination risk in ATMP manufacturing. Robotic gloveless isolators address that risk through full automation and real-time monitoring during aseptic filling.

• Stability Issues Unique To Liquid Injectables And How To Avoid Them

  3/23/2026

  Liquid injectables face stability risks like oxidation, hydrolysis, aggregation, temperature shifts, and packaging effects, requiring early, rigorous formulation and process controls.